Fingerprint
Dive into the research topics of 'Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically